Potential Of Kenikir (Cosmos Caudatus Kunth) Leaves Essential Oil Against Candida Albicans Atcc 10231 In Vitro
Potential Of Kenikir (Cosmos Caudatus Kunth) Leaves Essential Oil Against Candida Albicans Atcc 10231 In Vitro
DOI:
https://doi.org/10.36408/mhjcm.v9i3.803Keywords:
Cosmos caudatus Kunth, Candida albicans ATCC 10231 strains, diameter of the inhibition zoneAbstract
BACKGROUND : Kenikir is a medicinal plant whose leaves are often consumed as vegetables. Kenikir leaves contain active compounds such as flavonoids, polyphenols, saponins, tannins, alkaloids and essential oils. These compounds are thought to be able to inhibit the growth of Mycobacterium tuberculosa and Candida albicans ATCC 10231 strains
OBJECTIVE : The purpose of this study was to describe the effect of kenikir leaf essential oil on the growth of the Candida albicans ATCC 10231 strains. with 4 concentrations and 6 repetitions in Candida albicans and the concentration of kenikir leaf essential oil concentration of 0.5%, 1%, 1.5%, 2%,
METHOD : This type of research is a pure experimental research by providing treatment in the form of giving essential oil of kenikir leaves with various concentrations on the growth of the Candida albicans ATCC 10231 strains. The inhibition test of kenikir leaf essential oil on the growth of the Candida albicans ATCC 10231 strains was carried out using the Kirby Bauer disk diffusion method. The research design used is Post Test Only with Control Group Design.Data obtained in the form of inhibition zone diameter, were analyzed using Variant Analysis (Anova), P£ 0,05 and continued with Post Hoc test.
RESULT : The results showed that 0.5% essential oil concentration had a inhibition zone of 9.67 mm (moderate criteria); essential oil concentration of 1% with a inhibition zone of 9.72 mm with criteria moderate and 1.5% concentration with inhibition zone 11.86% with strong criteria and concentration 2% with inhibition zone 12.67 mm with strong criteria all concentrations affect the growth of Candida albicans with the most optimal concentration of 2% for the Candida albicans ATCC 10231 strains.
CONCLUSION : The higher the concentration of kenikir leaf extract, the inhibitory effect on the growth of Candida albicans ATCC 10231 strains was also higher.
KEYWORDS : Cosmos caudatus Kunth, Candida albicans ATCC 10231 strains, diameter of the inhibition zone
Downloads
References
Tyas A. Diajukan sebagai Salah Satu Syarat untuk Memperoleh Gelar Ahli Madya Analis Kesehatan. Published online 2019:76.
Jiwintarum Y, Urip U, Wijaya AF, Diarti MW. NATURAL MEDIA FOR THE GROWTH OF CANDIDA ALBICANS CAUSES OF CANDIDIASIS BY ARTOCARPUS COMMUNIS. JKP. 2018;11(2):158. doi:10.32807/jkp.v11i2.10
Suryani AE. Diajukan untuk Memenuhi Salah Satu Syarat Meraih Gelar Sarjana Sains Jurusan Fisika Fakultas Sains dan Teknologi UIN Alauddin Makassar. :89.
Ardizzoni A, Boaretto G, Pericolini E, et al. Effects of benzydamine and mouthwashes containing benzydamine on Candida albicans adhesion, biofilm formation, regrowth, and persistence. Clin Oral Invest. 2022;26(4):3613-3625. doi:10.1007/s00784-021-04330-8
Holmes IV JH, Connolly NC, Paull DL, et al. Magnitude of the inflammatory response to cardiopulmonary bypass and its relation to adverse clinical outcomes. Inflamm res. 2002;51(12):579-586. doi:10.1007/PL00012432
Wenas DM, Ramadania F. Aktivitas Antifungi Ekstrak Daun dan Kulit Jeruk Pamelo (Citrus maxima (Burm.) Merr.) terhadap Trichophyton mentagrophytes. Journal of Science and Technology. 2:9.
Revie NM, Iyer KR, Maxson ME, et al. Targeting fungal membrane homeostasis with imidazopyrazoindoles impairs azole resistance and biofilm formation. Nat Commun. 2022;13(1):3634. doi:10.1038/s41467-022-31308-1
Fauzi M, Lely N. KARAKTERISASI DAN UJI AKTIVITAS ANTIMIKROBA MINYAK. Published online 2017:8.
Ristiansyah DU. UJI EFEKTIVITAS ANTIBIOTIK EKSTRAK DAUN CENGKEH (SYZYGIUM AROMATICUM) TERHADAP PERTUMBUHAN BAKTERI SALMONELLA TYPHI SECARA IN VITRO. 2018;2(1):7.
Taweechaisupapong S, Ngaonee P, Patsuk P, Pitiphat W, Khunkitti W. Antibiofilm activity and post antifungal effect of lemongrass oil on clinical Candida dubliniensis isolate. South African Journal of Botany. 2012;78:37-43. doi:10.1016/j.sajb.2011.04.003
Wahyuningsih R, SahBandar IN, Theelen B, et al. Candida nivariensis Isolated from an Indonesian Human Immunodeficiency Virus-Infected Patient Suffering from Oropharyngeal Candidiasis. J Clin Microbiol. 2008;46(1):388-391. doi:10.1128/JCM.01660-07
Santi Perawati, Lili Andriani, Melianti D. AKTIVITAS ANTIFUNGI DARI EKSTRAK (Mikania micrantha Kunth) TERHADAP Trichophyton mentagrophytes dan Trichophyton rubrum: AKTIVITAS ANTIFUNGI DARI EKSTRAK (Mikania micrantha Kunth) TERHADAP Trichophyton mentagrophytes dan Trichophyton rubrum. BIOSENSE. 2021;4(02):9-19. doi:10.36526/biosense.v4i02.1543
Arendrup MC. Susceptibility and Epidemiology. :32.
Sari ER, Nugraheni ER. Uji aktivitas antifungi ekstrak etanol daun cabai jawa (Piper retrofractum) terhadap pertumbuhan candida albicans. J Nat Prod Biochem. 2013;11(2):36-42. doi:10.13057/biofar/f110202
Healy CM, Campbell JR, Zaccaria E, Baker CJ. Fluconazole Prophylaxis in Extremely Low Birth Weight Neonates Reduces Invasive Candidiasis Mortality Rates Without Emergence of Fluconazole-Resistant Candida Species. Pediatrics. 2008;121(4):703-710. doi:10.1542/peds.2007-1130
Mba IE, Nweze EI. Mechanism of Candida pathogenesis: revisiting the vital drivers. Eur J Clin Microbiol Infect Dis. 2020;39(10):1797-1819. doi:10.1007/s10096-020-03912-w
Siddik MB. KETOKONAZOL 2% TERHADAP Candida albicans. :8.
Madeira PLB, Carvalho LT, Paschoal MAB, et al. In vitro Effects of Lemongrass Extract on Candida albicans Biofilms, Human Cells Viability, and Denture Surface. Front Cell Infect Microbiol. 2016;6. doi:10.3389/fcimb.2016.00071
Additional Files
Published
How to Cite
Issue
Section
Citation Check
License
Copyright (c) 2022 Siti Zainatun Wasilah
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.
